A carregar...
Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate
Both erectile dysfunction (ED) and lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH) are common in the aging male. Numerous clinical trials have demonstrated the efficacy and safety of phosphodiesterase type 5 inhibitors (PDE5-Is) for treating LUTS/BPH with/without ED. However,...
Na minha lista:
| Publicado no: | Sci Rep |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4674741/ https://ncbi.nlm.nih.gov/pubmed/26657792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep17888 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|